000403.SZ Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 09:04):

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China...

Stats
Dagens volum	3.46M
Gjennomsnittsvolum	5.61M
Markedsverdi	21.75B
EPS	CNY0.250 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	38.79
ATR14	CNY0.0320 (0.11%)

Volum Korrelasjon

Lang: 0.07 (neutral)

Kort: 0.85 (strong)

Signal:(63.153) Same movement expected

Pacific Shuanglin Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Pacific Shuanglin Korrelasjon - Valuta/Råvare

0.18
( neutral )

0.32
( neutral )

0.00
( neutral )

0.31
( neutral )

0.33
( neutral )

-0.28
( neutral )

Pacific Shuanglin Økonomi

Annual	2023
Omsetning:	CNY2.33B
Bruttogevinst:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2023
Omsetning:	CNY2.33B
Bruttogevinst:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2022
Omsetning:	CNY2.41B
Bruttogevinst:	CNY1.25B (52.13 %)
EPS:	CNY0.800

FY	2021
Omsetning:	CNY1.97B
Bruttogevinst:	CNY908.43M (46.07 %)
EPS:	CNY0.554

Financial Reports:

No articles found.

Pacific Shuanglin

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.